YAP/TAZ-VGLL3 governs adipocyte fate via epigenetic reprogramming of PPARγ and its target enhancers
Science Advances · 2026
DOI: 10.1126/sciadv.aea7235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Taejun Seol und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Creative Research Center for Cell Plasticity, KAIST Stem Cell Center, Department of Biological Sciences, Korea Advanced Institute of Science…. Hauptthemen laut MEDLINE: PPAR gamma, Adipocytes, Transcription Factors, Enhancer Elements, Genetic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Adipocyte differentiation from mesenchymal stem cells is governed by tightly regulated transcriptional and epigenetic programs. The Hippo pathway effectors YAP and TAZ impede this process, yet the underlying molecular mechanisms remain unclear. Here, we demonstrate how YAP/TAZ regulate transcription of the adipocyte lineage specification factor PPARγ and its target genes at the chromatin level. TAZ represses PPARγ-bound target enhancers as evidenced by a markedly reduced histone H3 acetylated at lysine-27 occupancy, resulting in the transcriptional repression of adipogenic genes, including Pparg2 . Single-nucleus genomic analyses of mouse adipose tissue further revealed that YAP/TAZ activation drives extensive epigenetic modulation. Notably, the repressive effect of TAZ on adipogenic enhancers requires TEAD-dependent transcriptional activity, but not a direct interaction with PPARγ through the WW domain as previously reported. Last, we identified Vestigial-like 3 ( Vgll3 ) as a transcriptional target of TAZ critical for repressing adipogenic enhancers. These findings reveal that the YAP/TAZ-VGLL3 axis regulates adipocyte fate by repressing the PPARγ program at its target enhancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Creative Research Center for Cell Plasticity, KAIST Stem Cell Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
ORCID-Profile: Taejun Seol, Ju-Gyeong Kang, Kwangmin Ryu, Woojae Kim, Daehee Hwang, Suhyeon Cho, Bomin Ku, Yen T H Tran, Sun-Hye Jeong, Won-Ki Cho, Dae-Sik Lim
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
Zitieren
APA
Seol, T., Kang, J. G., Ryu, K., Kim, W., Hwang, D., Cho, S., Song, D., Ku, B., Tran, Y. T. H., Jeong, S. H., Cho, W. K., & Lim, D. S. (2026). YAP/TAZ-VGLL3 governs adipocyte fate via epigenetic reprogramming of PPARγ and its target enhancers. Science Advances. https://doi.org/10.1126/sciadv.aea7235
Vancouver
Seol T, Kang JG, Ryu K, Kim W, Hwang D, Cho S, et al. YAP/TAZ-VGLL3 governs adipocyte fate via epigenetic reprogramming of PPARγ and its target enhancers. Science Advances. 2026. doi:10.1126/sciadv.aea7235
BibTeX
@article{Seol2026,
author = {Seol, Taejun and Kang, Ju-Gyeong and Ryu, Kwangmin and Kim, Woojae and Hwang, Daehee and Cho, Suhyeon and Song, Daeun and Ku, Bomin and Tran, Yen T H and Jeong, Sun-Hye and Cho, Won-Ki and Lim, Dae-Sik},
title = {YAP/TAZ-VGLL3 governs adipocyte fate via epigenetic reprogramming of PPARγ and its target enhancers},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aea7235}
}
EUVIMED